ABSTRACT Bromovinyldeoxyuridine (BVdUrd) is a potent antiherpesvirus compound with low cytotoxicity. To gain an insight into its selectivity and mechanism of inhibition, we chemically synthesized the 5'-triphosphate of BVdUrd, BVdUTP, and (3, 4) ; in addition, a DNase (5) and a nucleoside phosphotransferase (6) are induced in cells upon infection with HSV. These virus-induced enzymes are significantly different from their cellular counterparts in many of their properties (7-9). For example, the HSV-induced DNA polymerase differs from the host cellular DNA polymerases a,
(EBV-as well as cellular DNA polymerases a, A3, and Ay. The effects on the DNA polymerases were determined under assay conditions optimal for the individual polymerases. We respec- tively. Kinetic analyses with the DNA polymerases a and p and the EBV DNA polymerase also reflected a similar difference in sensitivity between the HSV-1 enzyme and other enzymes. Increasing the concentration of either the DNA template or the enzyme in the reaction mixture did not bring about a significant change in the extent of inhibition. Preincubation of the inhibitor with the enzyme was not necessary for inhibition. Studies on time course of inhibition revealed that the compound is inhibitory even after the initiation of DNA synthesis. These studies indicate that the ability of BVdUTP to preferentially inhibit the HSV-1 DNA polymerase may contribute towards its selective inhibition of the viral DNA replication in infected cells.
In the past few years several compounds have been developed with antiviral activity; however, they have not been clinically useful because they are also toxic to uninfected cells. However, recent studies on the cellular events that occur after virus infection have led to an understanding of many steps specific for the infecting virus. There are several viral functions that can (3, 4) ; in addition, a DNase (5) and a nucleoside phosphotransferase (6) are induced in cells upon infection with HSV. These virus-induced enzymes are significantly different from their cellular counterparts in many of their properties (7) (8) (9) . For example, the HSV-induced DNA polymerase differs from the host cellular DNA polymerases a, /3, and 'y in elution profile on ion-exchange columns, molecular weight, primer template preference, effect of monovalent and divalent cations, and other requirements for maximal activity. From correlative studies to delineate specific roles that the cellular DNA polymerases play in DNA replication, it appears that the DNA polymerase a may be involved in chromosomal replication, DNA polymerase 3 in DNA repair, and DNA polymerase y in mitochondrial DNA synthesis (7) (8) (9) (10) . Genetic studies with HSV type 1 (HSV-1) have demonstrated that the virus-induced DNA polymerase is responsible for the replication of the viral DNA (11) .
These virus-induced enzymes lend themselves as exploitable targets for selective antiviral chemotherapy. Recent findings that some of the nucleoside analogs were preferentially phosphorylated by the herpesvirus-induced thymidine kinase marked a significant step forward in the development of antiviral chemotherapy (12) . Examples of such analogs include 1-f3-D-arabinofuranosylthymine (Ara-T) (13), 5-alkyl deoxyuridines (14) , 9 -(2-hydroxyethoxymethyl)guanine (acyclovir) (15), 2-fluro-5-iodo-1-/3-D-arabinofuranosylcytosine (FIAG) (16) , 5-substituted 2'-deoxycytidines and deoxyuridines, and 5-iodo-5'-amino-2',5'-dideoxyuridine (AIdUrd) (17) . Acyclovir, one of the most promising antiherpesviral agents developed in recent years, possesses antiviral activity against both types of HSV (type 1 and type 2) in cell culture as well as in experimental animal infections (18) .
A more recently synthesized nucleoside analog, (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVdUrd), was found to be a very potent and selective antiherpesvirus agent (19) . It inhibited HSV-1 replication in cell culture at concentrations as low as 0.007-0.01 jug/ml, levels 1/10,000th of the concentration at which normal cell metabolism was altered. In animal model systems-i.e., cutaneous herpesvirus infection in athymic nude mice-either topical or systemic administration of BVdUrd suppressed the development ofherpetic skin lesions and mortality.
BVdUrd belongs to the group of nucleoside analogs that are preferentially phosphorylated by the herpesvirus-induced thymidine kinase, because it is ineffective in suppressing herpesvirus replication when cells are infected with thymidine kinase mutants ofHSV-1 (20 (21) . The synthesis of BVdUrd was described by Jones et al. (22) .
BVdUrd was converted to the corresponding 5'-monophosphate (BVdUMP) in high yield by POClJPO(OEt)3 (23) and purified by column chromatography on DEAE-Sephadex using a linear gradient of triethylammonium bicarbonate between 0 and 400 mM at 40C. The monophosphate eluted at 200 mM salt. Activation ofthe monophosphate with 1, 1'-carbonyldiimidazole afforded the corresponding phosphorimidazolidate, which was condensed with di(tri-n-butylammonium) pyrophosphate (24) . Purification on DEAE-Sephadex with a linear gradient of triethylammonium bicarbonate between 0 and 800 mM afforded the desired product (elution at 400 mM). Phosphate assay by the method of Fischer (25) The reaction mixture for assaying DNA polymerase y activity contained 50 mM Tris HCI at pH 8.5, 2 mM dithiothreitol, 0.8 mM MnCl2, 10 ,uM [3H]dTTP (4300 cpm/pmol), 1 ,ug of (dT)-15-(A)n, 100 mM KCl, 20 jig ot bovine serum albumin, and enzyme. Other conditions were similar to those described above for measuring DNA polymerase a activity.
The reaction mixture for assaying HSV-1 DNA polymerase activity contained 50 mM Tris HCl at pH 8.3, 2 mM dithiothreitol, 4 mM MgCI2, 10 ,M each ofdATP, dCTP, and dGTP, 2 ,M [3H]dTTP (4300 cpm/pmol), 5 ,ug ofactivated calfthymus DNA, 50 mM ammonium sulfate, 10 ,g of bovine serum albumin, 5-10% glycerol, and enzyme. Other conditions were similar to those described above for measuring DNA polymerase a activity.
EBV DNA polymerase activity was assayed under conditions similar to those for DNA polymerase a except 4 mM MgCl2, 40 AM [3H]dTTP, and 100 mM KCI were used.
RESULTS
Relative Sensitivities of the Polymerases to BVdUTP Inhibition. The polymerases purified by DNA-cellulose column chromatography were used in all experiments, except the one to determine the relative sensitivities to BVdUTP inhibition. These enzymes were free of cross-contamination; for example, the HSV-1 DNA polymerase was free ofDNA polymerase a and vice versa. The HSV-1 DNA polymerase and DNA polymerase a were clearly separated on a phosphocellulose column; they were further purified by DNA-cellulose column chromatography. Furthermore, the assay conditions optimal for HSV-1 DNA polymerase were inhibitory to the DNA polymerase a activity. For example, at conditions optimal for HSV-1 DNA Biochemistry: Allaudeen et al. Similar experiments with other DNA polymerases showed that the mode of inhibition for all the polymerases is the same, although concentrations of the inhibitor necessary to bring about a 50% inhibition were different. EBV DNA polymerase results are shown in Fig. 3 ; DNA polymerase a, in Fig. 4 ; and DNA polymerase f3, in Fig. 5 . The Km values for dTTP and the Ki values for BVdUTP are shown in Table 2 .
Time Course. To determine whether BVdUTP could inhibit DNA synthesis even after the reaction was initiated, it was added to the ongoing reaction at different times and the activity was monitored. Fig. 6 illustrates that the compound caused an instantaneous inhibition whether it was added at the beginning or after the initiation of the reaction.
Preincubation. To 
